NCT06400927 Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure
| NCT ID | NCT06400927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | East and North Hertfordshire NHS Trust |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-05-07 |
| Primary Completion | 2027-06-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-05-07 with a primary completion date of 2027-06-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge Exclusion Criteria * Known prior history of HF * Severe comorbidities that could affect protocol adherence, in the opinion of the investigator * Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease * Dementia or other cognitive impairment * Currently involved in another interventional clinical trial
Contact & Investigator
Diana A Gorog, MD, PhD
PRINCIPAL INVESTIGATOR
East and North Hertfordshire NHS Trust
Frequently Asked Questions
Who can join the NCT06400927 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06400927 currently recruiting?
Yes, NCT06400927 is actively recruiting participants. Contact the research team at joshua.leader@nhs.net for enrollment information.
Where is the NCT06400927 trial being conducted?
This trial is being conducted at Stevenage, United Kingdom.
Who is sponsoring the NCT06400927 clinical trial?
NCT06400927 is sponsored by East and North Hertfordshire NHS Trust. The principal investigator is Diana A Gorog, MD, PhD at East and North Hertfordshire NHS Trust. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.